Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 20

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Cases. Jul 16, 2022; 10(20): 6900-6914
Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.6900

Table 3 Top 9 genes based on the network of ingredients and overlapping targets

Citation: Cui XY, Wu X, Lu D, Wang D. Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus. World J Clin Cases 2022; 10(20): 6900-6914
URL: https://www.wjgnet.com/2307-8960/full/v10/i20/6900.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i20.6900

Cui XY, Wu X, Lu D, Wang D. Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus. World J Clin Cases 2022; 10(20): 6900-6914 [PMID: 36051114 DOI: 10.12998/wjcc.v10.i20.6900]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.